Charles River Laboratories
Massachusetts
Pharmaceuticals Biotechnology and Life Sciences
Corporate Bias Rating
Expand Summary
Risk Level:
High Risk
Summary:
Charles River Laboratories is High Risk. The company yields to political activism in shaping corporate governance, potentially alienating consumers, dividing employees, and harming shareholders. The company implements race and identity-based policies that replace merit, excellence, and integrity with preferential treatment and outcomes. Charles River embraces corporate initiatives that redirect its central focus from business goals to partisan policies and divisive issues. This approach fails to safeguard free exercise, free speech, and free enterprise.
View Full Corporate Bias Ratings ReportShareholder Proposals
Expand Summary
| Date | ESG Category | Proponent | Summary of Resolution | Mgmt Rec | Total Vote % in Favor |
|---|---|---|---|---|---|
| 5/9/23 | Social | PETA | Report on Non-Human Primate Use/Welfare | Against | 35.80% |